BioMedomics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $3.96M

  • Investors
  • 7

BioMedomics General Information

Description

Developer of a clinical diagnostics technology designed to detect diseases with its point-of-care products. The company's immunologically based, disease-specific technology and quantitative platforms are used to analyze cell-based assay procedures, enabling physicians to diagnose diseases and enhance patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1100 Perimeter Park Drive
  • Suite 104
  • Morrisville, NC 27560
  • United States
+1 (919)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1100 Perimeter Park Drive
  • Suite 104
  • Morrisville, NC 27560
  • United States
+1 (919)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMedomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 12-Nov-2025 $3.96M Completed Generating Revenue
6. Grant 09-Aug-2017 Completed Generating Revenue
5. Later Stage VC (Series B2) 28-Jul-2017 Completed Generating Revenue
4. Later Stage VC (Series B1) 12-Dec-2016 Completed Generating Revenue
3. Debt - General 04-Mar-2016 Completed Generating Revenue
2. Later Stage VC (Series B) 23-Feb-2015 $276K $966K Completed Generating Revenue
1. Later Stage VC (Series A) 06-Jan-2014 $690K $690K Completed Generating Revenue
To view BioMedomics’s complete valuation and funding history, request access »

BioMedomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2
Series B1
Series B 922,737 $0.001000 $1.45 $1.45 1x $1.45 13.37%
Series A 1,293,750 $0.001000 $0.8 $0.8 1x $0.8 18.75%
To view BioMedomics’s complete cap table history, request access »

BioMedomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical diagnostics technology designed to detect diseases with its point-of-care products. The company'
Diagnostic Equipment
Morrisville, NC
14 As of 2025

Portland, OR
 

Santa Clara, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioMedomics Competitors (2)

One of BioMedomics’s 2 competitors is Hemex Health, a Venture Capital-Backed company based in Portland, OR.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hemex Health Venture Capital-Backed Portland, OR
Micropoint Formerly VC-backed Santa Clara, CA
You’re viewing 2 of 2 competitors. Get the full list »

BioMedomics Patents

BioMedomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2017139478-A1 Devices systems and methods for quantifying hemoglobin s concentration Inactive 09-Feb-2016
US-20190041407-A1 Devices, systems and methods for quantifying hemoglobin s concentration Inactive 09-Feb-2016
WO-2017062946-A1 Lateral flow immunoassay devices, systems and methods for detecting α-thalassemia 1 trait southeast asian (sea) type Inactive 08-Oct-2015
US-20160116489-A1 Lateral flow immunoassay method of simultaneously detecting hemoglobin s, hemoglobin c, and hemoglobin a in newborns, infants, children, and adults Pending 23-Oct-2014
US-20240361342-A1 Lateral flow immunoassay method of simultaneously detecting hemoglobin s, hemoglobin c, and hemoglobin a in newborns, infants, children, and adults Pending 23-Oct-2014 G01N33/721
To view BioMedomics’s complete patent history, request access »

BioMedomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioMedomics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eunice Kennedy Shriver National Institute of Child Health and Human Development Government
National Cancer Institute Government
National Heart, Lung, and Blood Institute Government
National Institute on Drug Abuse (NIDA) Government
NC Idea Accelerator/Incubator
You’re viewing 5 of 7 investors. Get the full list »

BioMedomics FAQs

  • When was BioMedomics founded?

    BioMedomics was founded in 2007.

  • Where is BioMedomics headquartered?

    BioMedomics is headquartered in Morrisville, NC.

  • What is the size of BioMedomics?

    BioMedomics has 14 total employees.

  • What industry is BioMedomics in?

    BioMedomics’s primary industry is Diagnostic Equipment.

  • Is BioMedomics a private or public company?

    BioMedomics is a Private company.

  • What is the current valuation of BioMedomics?

    The current valuation of BioMedomics is .

  • What is BioMedomics’s current revenue?

    The current revenue for BioMedomics is .

  • How much funding has BioMedomics raised over time?

    BioMedomics has raised $2.25M.

  • Who are BioMedomics’s investors?

    Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Cancer Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse (NIDA), and NC Idea are 5 of 7 investors who have invested in BioMedomics.

  • Who are BioMedomics’s competitors?

    Hemex Health and Micropoint are competitors of BioMedomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process